STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
May 01 2024 - 7:00AM
Business Wire
New Appointments Underscore Commitment to
Driving Innovation and Industry-Leading Growth
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of the EVO family of Implantable
Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia,
today announced Nancy Sabin has been named Chief Marketing Officer
and Nathaniel Sisitsky has been named General Counsel. Both will
serve on the Company’s executive committee and report to Tom
Frinzi, STAAR Surgical’s President and CEO.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240501408389/en/
Nancy Sabin, Chief Marketing Officer,
STAAR Surgical (Photo: Business Wire)
“We are thrilled to strengthen the STAAR team with the addition
of Nancy and Nate, two seasoned executives with extensive senior
leadership experience. They will play an integral role in
accelerating our momentum and thereby growing the market for our
surgeon customers who provide patients visual freedom from contact
lenses and glasses with our lens-based technology,” said Tom
Frinzi, President and CEO of STAAR Surgical. “Nancy is a perfect
fit for the newly created Chief Marketing Officer position and will
be critical to driving our brand awareness and innovation globally.
She is a proven commercial leader with an extensive track record of
delivering growth within consumer products, OTC pharmaceuticals and
medical devices during her 20-year career with various franchises
at Johnson & Johnson. Nate takes on an important role as our
new General Counsel overseeing our legal functions globally. Nate
brings to STAAR extensive experience providing legal advice and
counsel to public companies, including 15 years in med-tech. He
joins us from NuVasive where he was instrumental in its successful
$3 billion merger with Globus Medical.”
Frinzi continued, “I would like to express my utmost gratitude
to Sam Gesten, STAAR’s former general counsel, who retired after 12
years of service earlier this year. We are grateful for his
tireless work in moving the company forward and wish him all the
very best in the future.”
Nancy Sabin joined the team from Johnson & Johnson (J&J)
where she most recently served as VP of Marketing and Connected
Commerce for J&J Vision managing based marketing, digital
strategy and connected commerce functions for the ACUVUE™ contact
lens business in the U.S., one of J&J’s businesses with annual
sales of at least $1 billion. Prior, she led Global Marketing for
J&J Vision on the surgical side, driving innovation and equity
for its industry leading global intraocular lenses. She has also
held marketing leadership roles across J&J Consumer and J&J
MedTech; with responsibility for driving growth and building global
brands like TYLENOL™; ZYRTEC™ and ETHICON™. Nancy holds an M.B.A.
from the University of Pennsylvania’s Wharton School of Business
and a B.S. in Engineering from Duke University.
Ms. Sabin stated, “I am delighted to be a part of STAAR during
this critical phase in the company's growth. I am a huge believer
in the transformation made possible thanks to our EVO ICLs and look
forward to elevating the STAAR and EVO brands among surgeons and
their patients. I am excited and honored to lead our marketing
teams worldwide.”
Nathaniel Sisitsky joined STAAR Surgical from NuVasive, Inc., a
medical device company, where he served as Senior Vice President,
General Counsel and Corporate Secretary since 2018. Prior to
joining NuVasive, he served as Vice President and Associate General
Counsel at CareFusion Corporation, a global medical technology
company, and as Vice President, Legal – Corporate Finance at
American Tower Corporation, a global owner and operator of wireless
communication sites. Prior to joining American Tower, Nate was a
Junior Partner in the Corporate Department of Wilmer Cutler
Pickering Hale and Dorr (WilmerHale). He holds a J.D. from New York
University School of Law and a B.A. in Political Science and
Economics from Emory University.
“I am thrilled to join the STAAR leadership team at a time of
significant opportunity and growth for our vision correction
lenses,” said Nate Sisitsky.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™
product line. More than 3,000,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501408389/en/
Investors & Media Brian Moore Vice President,
Investor Relations and Corporate Development (626) 303-7902, Ext.
3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Oct 2024 to Oct 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Oct 2023 to Oct 2024